Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
12 participants
OBSERVATIONAL
2016-09-30
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BioPoly RS Knee Registry Study for Cartilage Defect Replacement
NCT01473199
BioPoly® Partial Resurfacing Knee Implant IDE
NCT06915363
Autologous Chondrocyte Implantation in the Patellofemoral Joint
NCT00212849
Investigation of a Customized Femoral Resurfacing Implant
NCT01690689
A Prospective Study to Evaluate the iTotal Knee and iPoly XE Tibial Inserts
NCT03289754
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BioPoly RS Partial Resurfacing Patella Implant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cartilage lesion(s) located in the facets of the patella that have failed prior therapy (conservative or surgical)
* Symptomatic lesions classified as ICRS grade 2, 3, or 4
* Lesion size may not exceed 3.1 cm2 and must be circumscribed by a 15 mm or 20 mm circle of normal or nearly normal (ICRS Grade 0 or 1) cartilage, with an overall depth less than 4 mm from the articulating surface
* Subchondral bone quality sufficient to support the implant
* Understanding and willingness to comply with the post-operative rehabilitation instructions and follow-up visits.
Exclusion Criteria
* Generalized degenerative or autoimmune arthritis
* Gout
* Uncorrected chronic malalignment of the patella (may be corrected at the same time as the implantation of the BioPoly device).
* Uncorrected ligamentous instability (may be corrected at the same time as the implantation of the BioPoly device).
* Kissing lesion on femur
* More than one implant required to accommodate lesion
* Allergy to ultra-high molecular weight polyethylene (UHMWPE), or hyaluronan/ hyaluronic acid (HA)
* Use with opposing articulating femoral components
* Any concomitant painful or disabling disease of the spine, hips, or lower limbs that would interfere with evaluation of the afflicted knee
* Pregnant, prisoner, vulnerable population, or unable to provide informed consent.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BioPoly LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dinesh Nathwani, MD
Role: PRINCIPAL_INVESTIGATOR
Charing Cross Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charing Cross Hospital
London, England, United Kingdom
Mid Yorkshire Hosp NHS
Wakefield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1251001 V2.0
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.